Qianjiang Yongan Pharmaceutical Co (SZSE:002365) GF Value : ¥6.20 (As of Jun. 05, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-05), Qianjiang Yongan Pharmaceutical Co's share price is ¥7.07. Qianjiang Yongan Pharmaceutical Co's GF Value is ¥6.20. Therefore, Qianjiang Yongan Pharmaceutical Co's Price-to-GF-Value for today is 1.14.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Qianjiang Yongan Pharmaceutical Co is Modestly Overvalued.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Qianjiang Yongan Pharmaceutical Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	7.07	/	6.20
	=	1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qianjiang Yongan Pharmaceutical Co GF Value Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » GF Value

Traded in Other Exchanges

N/A

Address

No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100

Website

http://www.chinataurine.com

Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.

Executives

Mei Song Lin	Executives
Wang Zhi Hua	Executives
Hong Ren Gui	Executives
Wu Yu Xi	Directors, executives
Dai Xiang Zhen	Executives
Wu Xiao Bo	Directors, executives
Luo Bai Neng	Executives
Ding Hong Li	Directors, executives
Fang Xi Quan	Executives
Li Shao Bo	Executives
Deng Yong Hong	Securities Affairs Representative
Dong Shi Hao	Executives
Wu Guo Sen	Supervisors
Lv Xin Wu	Executives
Chen Yong	Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines